Página principal > Resultados de la búsqueda: Couriel, D.R.
  Consejos para la búsqueda
Búsqueda avanzada
Buscar colecciones:
Ordenar por: Mostrar resultados: Formato de visualización:
Resultados globales: 2 registros encontrados en 0.03 segundos.
Artículos, Encontrados 2 registros
Artículos Encontrados 2 registros  
1.
9 p, 406.9 KB Impact of T Cell Dose on Outcome of T Cell-Replete HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation / Saad, Ayman (The Ohio State University) ; Lamb, Lawrence (University of Alabama at Birmingham) ; Wang, Tao (Medical College of Wisconsin) ; Hemmer, Michael T. (Medical College of Wisconsin) ; Spellman, Stephen (National Marrow Donor Program/Be the Match) ; Couriel, Daniel R (Utah Blood and Marrow Transplant Program) ; Alousi, Amin (Anderson Cancer Center) ; Pidala, Joseph (H. Lee Moffitt Cancer Center) ; Abdel-Azim, Hisham (University of Southern California Keck School of Medicine) ; Agrawal, Vaibhav (Indiana University School of Medicine) ; Aljurf, Mahmoud (King Faisal Specialist Hospital and Research Centre (Aràbia Saudita)) ; Beitinjaneh, Amer (University of Miami) ; Bhatt, Vijaya Raj (University of Nebraska Medical Center) ; Buchbinder, David Kyle (Children's Hospital of Orange County) ; Byrne, Michael (Vanderbilt University Medical Center) ; Cahn, Jean-Yves (CHU Grenoble Alpes) ; Cairo, Mitchell S. (New York Medical College) ; Castillo, Paul A. (UF Health Shands Children's Hospital) ; Chhabra, Saurabh (Medical College of Wisconsin) ; Diaz, Miguel Angel (Hospital Infantil Universitario Nino Jesus) ; Farhan, Shatha (Henry Ford Hospital Bone Marrow Transplant Program) ; Floisand, Yngvar (The National Hospital) ; Frangoul, Haydar A. (Children's Hospital at TriStar Centennial and Sarah Cannon Research Institute) ; Gadalla, Shahinaz M. (National Cancer Institute) ; Gajewski, James (Consultant at Lu Daopei Hospital) ; Gale, Robert Peter (Imperial College London) ; Gandhi, Manish (Mayo Clinic) ; Gergis, Usama (New York Presbyterian Hospital/Weill Cornell Medical Center) ; Hamilton, Betty (Cleveland Clinic Taussig Cancer Institute) ; Hematti, Peiman (University of Wisconsin Hospital and Clinics) ; Hildebrandt, Gerhard C. (University of Kentucky) ; Kamble, Rammurti T. (Baylor College of Medicine) ; Kanate, Abraham S. (West Virginia University) ; Khandelwal, Pooja (Cincinnati Children's Hospital Medical Center) ; Lazaryn, Aleksandr (H. Lee Moffitt Cancer Center) ; MacMillan, Margaret (University of Minnesota Blood and Marrow Transplant Program) ; Marks, David I. (University Hospitals Bristol NHS Trust) ; Martino Bofarull, Rodrigo (Institut d'Investigació Biomèdica Sant Pau) ; Mehta, Parinda A. (Cincinnati Children's Hospital Medical Center) ; Nishihori, Taiga (H. Lee Moffitt Cancer Center) ; Olsson, Richard (Uppsala University) ; Patel, Sagar (Cleveland Clinic Foundation) ; Qayed, Muna (Emory University School of Medicine) ; Rangarajan, Hemalatha G. (Nationwide Children's Hospital) ; Reshef, R. (Columbia University Medical Center) ; Ringden, O. (Karolinska Institutet (Estocolm, Suècia)) ; Savani, B.N. (Vanderbilt University Medical Center) ; Schouten, H.C. (Academische Ziekenhuis) ; Schultz, K.R. (The University of British Columbia) ; Seo, S. (Dokkyo Medical University) ; Shaffer, B.C. (Memorial Sloan Kettering Cancer Center) ; Solh, M. (Northside Hospital) ; Teshima, T. (Hokkaido University Hospital) ; Urbano-Ispizua, Alvaro (Hospital Clínic i Provincial de Barcelona) ; Verdonck, L.F. (Isala Clinic) ; Vij, R. (Washington University School of Medicine) ; Waller, E.K. (Emory University) ; William, B. (The Ohio State University) ; Wirk, B. (Seattle Cancer Care Alliance) ; Yared, J.A. (University of Maryland) ; Yu, L.C. (Children's Hospital/Louisiana State University Medical Center) ; Arora, M. (University of Minnesota Medical Center) ; Hashmi, S. (Mayo Clinic) ; Universitat Autònoma de Barcelona
Data on whether the T cell dose of allogeneic peripheral blood stem cell (PBSC) products influences transplantation outcomes are conflicting. Using the Center for International Blood and Marrow Transplant Research database, we identified 2736 adult patients who underwent first allogeneic PBSC transplantation for acute leukemia or myelodysplastic syndrome between 2008 and 2014 using an HLA-matched sibling donor (MSD) or an 8/8-matched unrelated donor (MUD). [...]
2019 - 10.1016/j.bbmt.2019.05.007
Biology of blood and marrow transplantation, Vol. 25 Núm. 9 (september 2019) , p. 1875-1883  
Registro completo - Creative Commons
2.
13 p, 850.9 KB Comparative Analysis of Calcineurin Inhibitor-Based Methotrexate and Mycophenolate Mofetil-Containing Regimens for Prevention of Graft-versus-Host Disease after Reduced-Intensity Conditioning Allogeneic Transplantation / Chhabra, Saurabh (Medical College of Wisconsin) ; Liu, Ying (Medical College of Wisconsin) ; Hemmer, Michael T. (Medical College of Wisconsin) ; Costa, Luciano (University of Alabama at Birmingham. Department of Medicine) ; Pidala, Joseph A. (H. Lee Moffitt Cancer Center and Research Institute) ; Couriel, Daniel R. (Utah Blood and Marrow Transplant Program) ; Alousi, Amin M. (University of Texas MD Anderson Cancer Center) ; Majhail, Navneet S. (Cleveland Clinic Taussig Cancer Institute) ; Stuart, Robert K. (Medical University of South Carolina) ; Kim, Dennis (Princess Margaret Cancer Center) ; Ringden, Olle (Karolinska Institutet (Estocolm, Suècia). Division of Therapeutic Immunology) ; Urbano Ispizua, Álvaro (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Saad, Ayman (University of Alabama at Birmingham) ; Savani, Bipin N. (Vanderbilt University Medical Center) ; Cooper, Brenda (University Hospitals Case Medical Center. Department of Medicine-Hematology and Oncology) ; Marks, David I. (University Hospitals Bristol NHS Trust) ; Socie, Gerard (Hôpital Saint Louis. Department of Hematology) ; Schouten, Harry C. (Academische Ziekenhuis. Department of Hematology) ; Schoemans, Helene (University Hospitals Leuven (Bèlgica)) ; Abdel-Azim, Hisham (University of Southern California Keck School of Medicine) ; Yared, Jean (University of Maryland. Greenebaum Cancer Center) ; Cahn, Jean-Yves (CHU Grenoble Alpes. Department of Hematology) ; Wagner, John (Thomas Jefferson University. Department of Medical Oncology) ; Antin, Joseph H. (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ; Verdonck, Leo F. (Isala Clinic. Departmentt of Hematology/Oncology) ; Lehmann, Leslie (Dana-Farber Cancer Institute (Boston, Estats Units d'Amèrica)) ; Aljurf, Mahmoud (King Faisal Specialist Hospital and Research Centre (Aràbia Saudita)) ; MacMillan, Margaret L. (University of Minnesota Blood and Marrow Transplant Program) ; Litzow, Mark R. (Mayo Clinic Rochester. Division of Hematology and Transplant Center) ; Solh, Melhem M. (Northside Hospital. Blood and Marrow Transplant Group of Georgia) ; Qayed, Muna (Emory University School of Medicine. Department of Pediatrics) ; Hematti, Peiman (University of Wisconsin) ; Kamble, Rammurti T. (Baylor College of Medicine) ; Vij, Ravi (Washington University School of Medicine. Division of Hematology and Oncology) ; Hayashi, Robert J. (Washington University School of Medicine in St. Louis. Division of Pediatric Hematology/Oncology) ; Gale, Robert Peter (Imperial College London. Hematology Research Centre) ; Martino Bofarull, Rodrigo (Institut d'Investigació Biomèdica Sant Pau) ; Seo, Sachiko (National Cancer Research Center East) ; Hashmi, Shahrukh K (Mayo Clinic Rochester. Division of Hematology and Transplant Center) ; Nishihori, Taiga (H. Lee Moffitt Cancer Center and Research Institute) ; Teshima, Takanori (Kyushu University Hospital) ; Gergis, Usama (New York Presbyterian Hospital/Weill Cornell Medical Center. Department of Medical Oncology) ; Inamoto, Yoshihiro (National Cancer Center Hospital) ; Spellman, Stephen R. (Center for International Blood and Marrow Transplant Research) ; Arora, Mukta (University of Minnesota Medical Center) ; Hamilton, Betty K. (Cleveland Clinic Taussig Cancer Institute) ; Universitat Autònoma de Barcelona
The combination of a calcineurin inhibitor (CNI) such as tacrolimus (TAC) or cyclosporine (CYSP) with methotrexate (MTX) or with mycophenolate mofetil (MMF) has been commonly used for graft-versus-host disease (GVHD) prophylaxis after reduced-intensity conditioning (RIC) allogeneic hematopoietic cell transplantation (alloHCT), but there are limited data comparing efficacy of the 2 regimens. [...]
2019 - 10.1016/j.bbmt.2018.08.018
Biology of blood and marrow transplantation, Vol. 25 Núm. 1 (january 2019) , p. 73-85  
Registro completo - Creative Commons

Vea también: autores con nombres similares
1 Couriel, Daniel
1 Couriel, Daniel R
1 Couriel, Daniel R.
¿Le interesa recibir alertas sobre nuevos resultados de esta búsqueda?
Defina una alerta personal vía correo electrónico o subscríbase al canal RSS.
Depósito Digital de Documentos de la UAB :: Buscar :: Enviar :: Personalizar :: Ayuda
Powered by Invenio v1.1.6
Mantenido por ddd.bib@uab.cat  :: Metadatos sujetos a:
Colaboramos